Benefits
Stress-Related Eating Support
In an 8-week randomized, double-blind, placebo-controlled trial in 52 adults under chronic stress, an ashwagandha root extract at 300 mg twice daily improved perceived stress scores, food cravings and eating-behaviour scores, and lowered body weight and BMI. That trial did not name Sensoril and did not test the SensorilTrim combination, so this is evidence for ashwagandha in general, in stressed adults, not for this branded blend.
Cortisol Balance
In the same 52-person trial, serum cortisol fell more with ashwagandha than with placebo over 8 weeks. The extract used was not identified as Sensoril, the participants were selected for chronic stress, and the trial did not measure belly fat or fat distribution, so any link to where fat sits on the body is an assumption rather than a finding.
Cardiovascular Risk Factor Support
In a 12-week randomized trial in overweight and class-1 obese adults, Capros amla at 500 mg twice daily lowered LDL cholesterol, the total-cholesterol-to-HDL ratio and the inflammation marker hs-CRP. Oxidized LDL was not among the reported measures, and the study tested Capros on its own, a different branded ingredient, not SensorilTrim.
Antioxidant Defense
Amla fruit is rich in polyphenols, and antioxidant activity is the usual explanation offered for its effects. Neither study cited on this page measured any antioxidant marker in people, so treat this as background chemistry rather than a demonstrated benefit.
Mechanism of action
HPA-Axis Modulation (Ashwagandha)
Withanolides are thought to act on the body's stress-hormone system. In the one human trial cited here, an ashwagandha root extract lowered serum cortisol compared with placebo in 52 chronically stressed adults over 8 weeks. That extract was not identified as Sensoril, and the trial did not measure central body fat, so the step from cortisol to belly fat remains an untested idea.
Lipid and Inflammatory Pathway Effects (Amla)
In overweight and class-1 obese adults, Capros amla lowered LDL cholesterol and high-sensitivity C-reactive protein and reduced both ADP- and collagen-induced platelet aggregation. Reduced platelet aggregation means blood clots a little less readily, which matters if you take blood thinners or have surgery coming up. This was a separate study of Capros, not of SensorilTrim.
Oxidative Stress Reduction
Both plants show antioxidant activity in laboratory testing. Neither trial cited on this page measured malondialdehyde, glutathione or any other antioxidant marker, so this pathway is untested for this product.
Clinical trials
Randomized, double-blind, placebo-controlled trial of ashwagandha root extract 300 mg twice daily versus placebo for 8 weeks in 52 adults under chronic stress. Outcomes: perceived stress, food cravings, body weight, BMI, cortisol, eating behaviors.
52 chronically stressed adults, 8-week intervention.
Ashwagandha reduced perceived stress, food cravings and serum cortisol compared with placebo, and improved body weight, BMI, eating-behaviour scores and happiness scores. It was well tolerated. Limitations to keep in mind: only 52 people, only 8 weeks, and everyone was selected for chronic stress, so the results may not carry over to people who are not under that kind of stress. The extract was not identified as Sensoril and the SensorilTrim combination was not tested, and the dose used, 300 mg twice daily, is higher than the 125-250 mg of Sensoril twice daily usually listed.
Randomized clinical trial of Capros (Phyllanthus emblica) 500 mg twice daily for 12 weeks in overweight or class-1 obese adults. Outcomes: LDL, HDL, total cholesterol/HDL ratio, hs-CRP and platelet aggregation.
Overweight or class-1 obese adults, 12-week intervention with 2-week washout.
Capros amla lowered LDL cholesterol, the total-cholesterol-to-HDL ratio and hs-CRP, and reduced both ADP- and collagen-induced platelet aggregation. Two things to keep in mind: this tested Capros amla on its own, a different branded ingredient from SensorilTrim, and the drop in platelet aggregation means blood clots less readily, which is a bleeding consideration for anyone on blood thinners or heading into surgery.